The main purine analogues with activity against lymphoid malignancies are fludarabine, cladribine and pentostatin, all of which are active against slowly proliferating cells through their inhibition of DNA repair and therefore have significant synergistic activity with cytotoxic agents which cause D
✦ LIBER ✦
The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma
✍ Scribed by Luciano Mutti; Giovanni Gaudino
- Book ID
- 107615947
- Publisher
- PAGEPress Publications
- Year
- 2008
- Tongue
- English
- Weight
- 63 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1970-5557
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Therapeutic potential of purine analogue
✍
S. A. Johnson; W. Thomas
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
English
⚖ 94 KB
👁 2 views
The value of adriamycin in the treatment
✍
Boh-Seng Yap; Robert S. Benjamin; M. Andrew Burgess; Gerald P. Bodey
📂
Article
📅
1978
🏛
John Wiley and Sons
🌐
English
⚖ 391 KB
👁 2 views
Therapeutic potential of the dual-target
✍
Olaf H. Temmink; Tomohiro Emura; Michiel De Bruin; Masakazu Fukushima; Godefridu
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 378 KB
Menogaril in the treatment of malignant
✍
C. A. Hudis; D. P. Kelsen
📂
Article
📅
1992
🏛
Springer US
🌐
English
⚖ 275 KB
Therapeutic renaissance of thalidomide i
✍
Ribatti, D; Vacca, A
📂
Article
📅
2005
🏛
Nature Publishing Group
🌐
English
⚖ 122 KB
The potential role of lonidamine (LND) i
✍
Carmine M. Carapella; Marco G. Paggi; Fabio Cattani; Giovanni B. Ciottoli; Arist
📂
Article
📅
1989
🏛
Springer US
🌐
English
⚖ 397 KB
Up-to-date unsatisfactory results obtained in multimodality treatments of malignant glioma have prompted the research of new therapeutic modalities with 'unconventional' modes of action. Lonidamine (LND) is a drug which reduces aerobic glycolytic activity in both human and experimental tumors. This